(Circulation. 1995;92:320-326.)
© 1995 American Heart Association, Inc.
Articles |
From the National Institutes of Health, Cardiology Branch, NHLBI, Bethesda, Md, and the Division of Cardiology, Medical College of Virginia, Richmond (D.M.G.).
Background The vascular endothelium contributes to smooth muscle relaxation by tonic release of nitric oxide. To investigate the contribution of nitric oxide to human coronary epicardial and microvascular dilation during conditions of increasing myocardial oxygen requirements, we studied the effect of inhibiting nitric oxide synthesis with NG-monomethyl-L-arginine (L-NMMA) on the coronary vasodilation during cardiac pacing in patients with angiographically normal coronary arteries with and without multiple risk factors for coronary atherosclerosis.
Methods and Results In 26 patients with angiographically normal or near-normal epicardial coronary arteries, metabolic vasodilation was assessed as a change in coronary vascular resistance and diameter during cardiac pacing (mean heart rate, 141 beats per minute). Endothelium-dependent vasodilation was estimated with intracoronary acetylcholine and endothelium-independent dilation with intracoronary sodium nitroprusside and adenosine. These measurements were repeated after 64 µmol/min intracoronary L-NMMA. At rest, L-NMMA produced a 16±25% (mean±SD) increase in coronary vascular resistance (P<.05) and an 11% reduction in distal epicardial coronary artery diameter (P<.01), indicating tonic basal release of nitric oxide from human coronary epicardial vessels and microvessels. Significant inhibition of pacing-induced metabolic coronary vascular dilation occurred with L-NMMA, coronary vascular resistance was 38±56% higher (P<.03), and epicardial coronary dilation during control pacing (9±13%) was converted to constriction after L-NMMA and pacing (-6±9%, P<.04). L-NMMA specifically inhibited endothelium-dependent vasodilation with acetylcholine (coronary vascular resistance was 72% higher [P<.01]) but did not alter endothelium-independent dilation with sodium nitroprusside and adenosine. Nine patients had no major risk factors for atherosclerosis, defined as serum cholesterol >240 mg/dL, hypertension, or diabetes. The remaining 17 patients with one or more of these risk factors had depressed microvascular vasodilation during cardiac pacing (coronary vascular resistance decreased by 13% versus 36% in those without risk factors, P<.05). The inhibitory effect of L-NMMA on pacing-induced coronary epicardial and microvascular vasodilation was observed only in patients without risk factors, whereas those with risk factors had an insignificant change, indicating that nitric oxide contributes significantly to pacing-induced coronary vasodilation in patients free of risk factors and without endothelial dysfunction. Patients with risk factors also had reduced vasodilation with acetylcholine (40±28% versus 68±8% decrease in coronary vascular resistance, P<.01), but the responses to sodium nitroprusside were similar in both groups.
Conclusions During metabolic stimulation of the human heart, nitric oxide release contributes significantly to microvascular vasodilation and is almost entirely responsible for the epicardial vasodilation. This contribution of nitric oxide is reduced in patients exposed to risk factors for coronary atherosclerosis and leads to a net reduction in vasodilation during stress. An important implication of these findings is that reduced nitric oxide bioavailability during stress in patients with atherosclerosis or risk factors for atherosclerosis may contribute to myocardial ischemia by limiting epicardial and microvascular coronary vasodilation.
Key Words: endothelium-derived factors vasodilation
This article has been cited by other articles:
![]() |
M. Seddon, N. Melikian, R. Dworakowski, H. Shabeeh, B. Jiang, J. Byrne, B. Casadei, P. Chowienczyk, and A. M. Shah Effects of Neuronal Nitric Oxide Synthase on Human Coronary Artery Diameter and Blood Flow In Vivo Circulation, May 26, 2009; 119(20): 2656 - 2662. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lavi, E. H. Yang, A. Prasad, V. Mathew, G. W. Barsness, C. S. Rihal, L. O. Lerman, and A. Lerman The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans Hypertension, January 1, 2008; 51(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Duncker and D. Merkus Exercise hyperaemia in the heart: the search for the dilator mechanism J. Physiol., September 15, 2007; 583(3): 847 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Choudhary, C. Antoniades, A. F. Brading, A. Galione, K. Channon, and D. P. Taggart Diabetes Mellitus as a Predictor for Radial Artery Vasoreactivity in Patients Undergoing Coronary Artery Bypass Grafting J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1047 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Raher, H. Thibault, K. K. Poh, R. Liu, E. F. Halpern, G. Derumeaux, F. Ichinose, W. M. Zapol, K. D. Bloch, M. H. Picard, et al. In Vivo Characterization of Murine Myocardial Perfusion With Myocardial Contrast Echocardiography: Validation and Application in Nitric Oxide Synthase 3 Deficient Mice Circulation, September 11, 2007; 116(11): 1250 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Neglia, R. De Maria, S. Masi, M. Gallopin, P. Pisani, S. Pardini, A. Gavazzi, A. L'Abbate, and O. Parodi Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy Heart, July 1, 2007; 93(7): 808 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Kuvin, A. Mammen, P. Mooney, A. A. Alsheikh-Ali, and R. H. Karas Assessment of peripheral vascular endothelial function in the ambulatory setting Vascular Medicine, February 1, 2007; 12(1): 13 - 16. [Abstract] [PDF] |
||||
![]() |
A. A. Quyyumi and M. Ozkor Vasodilation by Hyperpolarization: Beyond NO Hypertension, December 1, 2006; 48(6): 1023 - 1025. [Full Text] [PDF] |
||||
![]() |
C. Kusmic, G. Lazzerini, F. Coceani, R. Barsacchi, A. L'Abbate, and G. Sambuceti Paradoxical coronary microcirculatory constriction during ischemia: a synergic function for nitric oxide and endothelin Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1814 - H1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Neishi, S. Mochizuki, T. Miyasaka, T. Kawamoto, T. Kume, R. Sukmawan, M. Tsukiji, Y. Ogasawara, F. Kajiya, T. Akasaka, et al. Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration PNAS, August 9, 2005; 102(32): 11456 - 11461. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barbato, F. Piscione, J. Bartunek, G. Galasso, P. Cirillo, G. De Luca, G. Iaccarino, B. De Bruyne, M. Chiariello, and W. Wijns Role of {beta}2 Adrenergic Receptors in Human Atherosclerotic Coronary Arteries Circulation, January 25, 2005; 111(3): 288 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J. Physiol., November 15, 2004; 561(1): 1 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. O. Farouque, S. G. Worthley, and I. T. Meredith Effect of ATP-Sensitive Potassium Channel Inhibition on Coronary Metabolic Vasodilation in Humans Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 905 - 910. [Abstract] [Full Text] |
||||
![]() |
J. Gellman, J. M. Hare, C. J. Lowenstein, G. Gerstenblith, V. Coombs, P. Langenberg, J. A. Brinker, and J. R. Resar L-Arginine Ameliorates the Abnormal Sympathetic Response of the Dysfunctional Human Coronary Microvasculature Angiology, January 1, 2004; 55(1): 1 - 8. [Abstract] [PDF] |
||||
![]() |
P. Ganz and J. A. Vita Testing Endothelial Vasomotor Function: Nitric Oxide, a Multipotent Molecule Circulation, October 28, 2003; 108(17): 2049 - 2053. [Full Text] [PDF] |
||||
![]() |
D. Merkus, D. B. Haitsma, T.-Y. Fung, Y. J. Assen, P. D. Verdouw, and D. J. Duncker Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H424 - H433. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Bonetti, L. O. Lerman, and A. Lerman Endothelial Dysfunction: A Marker of Atherosclerotic Risk Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 168 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wessely, L. Hengst, B. Jaschke, F. Wegener, T. Richter, R. Lupetti, M. Paschalidis, A. Schomig, R. Brandl, and F.-J. Neumann A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia Hum. Mol. Genet., January 15, 2003; 12(2): 177 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. J. Halcox, K. R. A. Nour, G. Zalos, R. Mincemoyer, M. A. Waclawiw, C. E. Rivera, G. Willie, S. Ellahham, and A. A. Quyyumi The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1232 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Green, C. Cheetham, C. Henderson, R. Weerasooriya, and G. O'Driscoll Effect of cardiac pacing on forearm vascular responses and nitric oxide function Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1354 - H1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Green, C. Cheetham, L. Mavaddat, K. Watts, M. Best, R. Taylor, and G. O'Driscoll Effect of lower limb exercise on forearm vascular function: contribution of nitric oxide Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H899 - H907. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, J. Zhu, J. P.J. Halcox, M. A. Waclawiw, S. E. Epstein, and A. A. Quyyumi Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction Circulation, July 9, 2002; 106(2): 184 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Tune, K. N. Richmond, M. W. Gorman, and E. O. Feigl Control of Coronary Blood Flow during Exercise Experimental Biology and Medicine, April 1, 2002; 227(4): 238 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A.W. Broeders, G. J. Tangelder, D. W. Slaaf, R. S. Reneman, and M. G.A. oude Egbrink Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules: Complete Reversal by L-Arginine Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 680 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Joshi, H. Duong, S. Mangla, M. Wang, A. D. Libow, S. J. Popilskis, N. D. Ostapkovich, T. S. Wang, W. L. Young, and J. Pile-Spellman In Nonhuman Primates Intracarotid Adenosine, but Not Sodium Nitroprusside, Increases Cerebral Blood Flow Anesth. Analg., February 1, 2002; 94(2): 393 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Cannon III Oral L-arginine (and other active ingredients) for ischemic heart disease? J. Am. Coll. Cardiol., January 2, 2002; 39(1): 46 - 48. [Full Text] [PDF] |
||||
![]() |
M. Kimura, A.-M. Jefferis, H. Watanabe, and J. Chin-Dusting Insulin Inhibits Acetylcholine Responses in Rat Isolated Mesenteric Arteries via a Non-Nitric Oxide Nonprostanoid Pathway Hypertension, January 1, 2002; 39(1): 35 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Rim, H. Leong-Poi, J. R. Lindner, K. Wei, N. G. Fisher, and S. Kaul Decrease in Coronary Blood Flow Reserve During Hyperlipidemia Is Secondary to an Increase in Blood Viscosity Circulation, November 27, 2001; 104(22): 2704 - 2709. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia Circulation, November 6, 2001; 104(19): 2305 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, J. P. J. Halcox, M. A. Waclawiw, and A. A. Quyyumi Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1089 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, R. Mincemoyer, and A. A. Quyyumi Anti-ischemic effects of angiotensin- converting enzyme inhibition in hypertension J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1116 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maiorana, G. O'Driscoll, C. Cheetham, L. Dembo, K. Stanton, C. Goodman, R. Taylor, and D. Green The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes J. Am. Coll. Cardiol., September 1, 2001; 38(3): 860 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Lamping and F. M. Faraci Role of Sex Differences and Effects of Endothelial NO Synthase Deficiency in Responses of Carotid Arteries to Serotonin Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 523 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mullen, R. K. Kharbanda, J. Cross, A. E. Donald, M. Taylor, P. Vallance, J. E. Deanfield, and R. J. MacAllister Heterogenous Nature of Flow-Mediated Dilatation in Human Conduit Arteries In Vivo : Relevance to Endothelial Dysfunction in Hypercholesterolemia Circ. Res., February 2, 2001; 88(2): 145 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, S. Husain, W. Schenke, R. Mincemoyer, N. Epstein, and A. A. Quyyumi Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1467 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maiorana, G. O'Driscoll, L. Dembo, C. Cheetham, C. Goodman, R. Taylor, and D. Green Effect of aerobic and resistance exercise training on vascular function in heart failure Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1999 - H2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Duncker, R. Stubenitsky, P. A.L. Tonino, and P. D. Verdouw Nitric oxide contributes to the regulation of vasomotor tone but does not modulate O2-consumption in exercising swine Cardiovasc Res, September 1, 2000; 47(4): 738 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vita, A. C. Yeung, M. Winniford, J. M. Hodgson, C. B. Treasure, J. L. Klein, S. Werns, M. Kern, D. Plotkin, W. J. Shih, et al. Effect of Cholesterol-Lowering Therapy on Coronary Endothelial Vasomotor Function in Patients With Coronary Artery Disease Circulation, August 22, 2000; 102(8): 846 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Tune, K. N. Richmond, M. W. Gorman, and E. O. Feigl Role of Nitric Oxide and Adenosine in Control of Coronary Blood Flow in Exercising Dogs Circulation, June 27, 2000; 101(25): 2942 - 2948. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ammann, S. Marschall, M. Kraus, L. Schmid, W. Angehrn, R. Krapf, and H. Rickli Characteristics and Prognosis of Myocardial Infarction in Patients With Normal Coronary Arteries Chest, February 1, 2000; 117(2): 333 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sztajzel, F. Mach, and A. Righetti Current concepts in medicine: Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries Postgrad. Med. J., January 1, 2000; 76(891): 16 - 21. [Abstract] [Full Text] |
||||
![]() |
S. J. Duffy, S. F. Castle, R. W. Harper, and I. T. Meredith Contribution of Vasodilator Prostanoids and Nitric Oxide to Resting Flow, Metabolic Vasodilation, and Flow-Mediated Dilation in Human Coronary Circulation Circulation, November 9, 1999; 100(19): 1951 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Paulis, F. Tomai, A. Gaspardone, L. Colagrande, P. Nardi, A. Ghini, F. Versaci, A. P. de Peppo, P. A. Gioffre, and L. Chiariello CORONARY FLOW RESERVE EARLY AND LATE AFTER MINIMALLY INVASIVE CORONARY ARTERY BYPASS GRAFTING IN PATIENTS WITH TOTALLY OCCLUDED LEFT ANTERIOR DESCENDING CORONARY ARTERY J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 604 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Anderson Assessment and treatment of endothelial dysfunction in humans J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638. [Full Text] [PDF] |
||||
![]() |
S. J Duffy, G. New, R. W Harper, and I. T Meredith Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation Cardiovasc Res, August 15, 1999; 43(3): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, N. P. Andrews, F. A. Padder, M. Husain, and A. A. Quyyumi Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability J. Am. Coll. Cardiol., August 1, 1999; 34(2): 507 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miura, Y. Liu, and D. D. Gutterman Human Coronary Arteriolar Dilation to Bradykinin Depends on Membrane Hyperpolarization : Contribution of Nitric Oxide and Ca2+-Activated K+ Channels Circulation, June 22, 1999; 99(24): 3132 - 3138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakayama, H. Yasue, M. Yoshimura, Y. Shimasaki, K. Kugiyama, H. Ogawa, T. Motoyama, Y. Saito, Y. Ogawa, Y. Miyamoto, et al. T-786->C Mutation in the 5'-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm Circulation, June 8, 1999; 99(22): 2864 - 2870. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Costa, P. Sulur, M. Angel, J. Cavalcante, V. Haile, B. Christman, and I. Biaggioni Intravascular Source of Adenosine During Forearm Ischemia in Humans : Implications for Reactive Hyperemia Hypertension, June 1, 1999; 33(6): 1453 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, S. Husain, and A. A. Quyyumi Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin J. Am. Coll. Cardiol., March 1, 1999; 33(3): 796 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kal, I. Vergroesen, and H. B. van Wezel The Effect of Nitroglycerin on Pacing-Induced Changes in Myocardial Oxygen Consumption and Metabolic Coronary Vasodilation in Patients with Coronary Artery Disease Anesth. Analg., February 1, 1999; 88(2): 271 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rapps, P. R. Myers, Q. Zhong, and J. L. Parker Development of Endothelium-Dependent Relaxation in Canine Coronary Collateral Arteries Circulation, October 20, 1998; 98(16): 1675 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Quyyumi Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia?: A double-blind comparison of parenteral D- and L-Arginine J. Am. Coll. Cardiol., October 1, 1998; 32(4): 904 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bache Vasodilator Reserve : A Functional Assessment of Coronary Health Circulation, September 29, 1998; 98(13): 1257 - 1260. [Full Text] [PDF] |
||||
![]() |
J. G. Diodati, N. Dakak, D. M. Gilligan, and A. A. Quyyumi Effect of Atherosclerosis on Endothelium-Dependent Inhibition of Platelet Activation in Humans Circulation, July 7, 1998; 98(1): 17 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Node, M. Kitakaze, H. Sato, Y. Koretsune, M. Karita, H. Kosaka, and M. Hori Increased release of nitric oxide in ischemic hearts after exercise in patients with effort angina J. Am. Coll. Cardiol., July 1, 1998; 32(1): 63 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dakak, S. Husain, D. Mulcahy, N. P. Andrews, J. A. Panza, M. Waclawiw, W. Schenke, and A. A. Quyyumi Contribution of Nitric Oxide to Reactive Hyperemia : Impact of Endothelial Dysfunction Hypertension, July 1, 1998; 32(1): 9 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Costa and I. Biaggioni Role of Nitric Oxide in Adenosine-Induced Vasodilation in Humans Hypertension, May 1, 1998; 31(5): 1061 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Duffy, B. T. Tran, G. New, R. N. Tudball, M. D. Esler, R. W. Harper, and I. T. Meredith Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1174 - H1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Husain, N. P. Andrews, D. Mulcahy, J. A. Panza, and A. A. Quyyumi Aspirin Improves Endothelial Dysfunction in Atherosclerosis Circulation, March 3, 1998; 97(8): 716 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Godecke, U. K. M. Decking, Z. Ding, J. Hirchenhain, H.-J. Bidmon, S. Godecke, and J. Schrader Coronary Hemodynamics in Endothelial NO Synthase Knockout Mice Circ. Res., February 9, 1998; 82(2): 186 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fei, A. D. Baron, D. P. Henry, and D. P. Zipes Intrapericardial Delivery of L-Arginine Reduces the Increased Severity of Ventricular Arrhythmias During Sympathetic Stimulation in Dogs With Acute Coronary Occlusion : Nitric Oxide Modulates Sympathetic Effects on Ventricular Electrophysiological Properties Circulation, December 2, 1997; 96(11): 4044 - 4049. [Abstract] [Full Text] |
||||
![]() |
M. Kato, N. Shiode, T. Yamagata, H. Matsuura, and G. Kajiyama Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis Heart, November 1, 1997; 78(5): 493 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Giannella, H.-C. Mochmann, and R. Levi Ischemic Preconditioning Prevents the Impairment of Hypoxic Coronary Vasodilatation Caused by Ischemia/Reperfusion : Role of Adenosine A1/A3 and Bradykinin B2 Receptor Activation Circ. Res., September 19, 1997; 81(3): 415 - 422. [Abstract] [Full Text] |
||||
![]() |
T. Minamino, M. Kitakaze, K. Node, H. Funaya, and M. Hori Inhibition of Nitric Oxide Synthesis Increases Adenosine Production via an Extracellular Pathway Through Activation of Protein Kinase C Circulation, September 2, 1997; 96(5): 1586 - 1592. [Abstract] [Full Text] |
||||
![]() |
M. Kimura, I. Kurose, J. Russell, and D. N. Granger Effects of Fluvastatin on Leukocyte–Endothelial Cell Adhesion in Hypercholesterolemic Rats Arterioscler Thromb Vasc Biol, August 1, 1997; 17(8): 1521 - 1526. [Abstract] [Full Text] |
||||
![]() |
S. Joshi, W. L. Young, J. Pile-Spellman, P. Fogarty-Mack, R. R. Sciacca, L. Hacein-Bey, H. Duong, Y. Vulliemoz, N. Ostapkovich, and T. Jackson Intra-arterial Nitrovasodilators Do Not Increase Cerebral Blood Flow in Angiographically Normal Territories of Arteriovenous Malformation Patients Stroke, June 1, 1997; 28(6): 1115 - 1122. [Abstract] [Full Text] |
||||
![]() |
R. D. Bernstein, F. Y. Ochoa, X. Xu, P. Forfia, W. Shen, C. I. Thompson, and T. H. Hintze Function and Production of Nitric Oxide in the Coronary Circulation of the Conscious Dog During Exercise Circ. Res., October 1, 1996; 79(4): 840 - 848. [Abstract] [Full Text] |
||||
![]() |
K. Egashira, Y. Katsuda, M. Mohri, T. Kuga, T. Tagawa, T. Kubota, Y. Hirakawa, and A. Takeshita Role of Endothelium-Derived Nitric Oxide in Coronary Vasodilatation Induced by Pacing Tachycardia in Humans Circ. Res., August 1, 1996; 79(2): 331 - 335. [Abstract] [Full Text] |
||||
![]() |
D. H. McDermott, J. P.J. Halcox, W. H. Schenke, M. A. Waclawiw, M. N. Merrell, N. Epstein, A. A. Quyyumi, and P. M. Murphy Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis Circ. Res., August 31, 2001; 89(5): 401 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A.W. Broeders, G. J. Tangelder, D. W. Slaaf, R. S. Reneman, and M. G.A. oude Egbrink Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules: Complete Reversal by L-Arginine Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 680 - 685. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |